HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Plasmapheresis in the treatment of diseases caused by immunologic pathology].

Abstract
The authors discuss the results of the use of therapeutic plasmapheresis (290 sessions) in 56 patients with immunity-mediated diseases: hemorrhagic vasculitis, Goodpasture's syndrome, multiple sclerosis, Guillain-Barre's syndrome, rheumatoid arthritis, partial red cell aplasia, etc. Demonstrate the possibilities of the attainment of positive results provided plasmapheresis is included into the complex of therapeutic measures. Discuss the indications, criteria of the efficacy, and contraindications to plasmapheresis administration. Infer that the clinical data play the decisive role in the appraisal of the plasmapheresis efficacy. Recommend that intermittent plasmapheresis be widely used for the treatment of internal diseases.
AuthorsV M Gorodetskiĭ, V V Ryzhko
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 56 Issue 6 Pg. 19-23 ( 1984) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitlePlazmaferez v terapii zabolevaniĭ, obuslovlennykh immunnoĭ patologieĭ.
PMID6236574 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Adult
  • Anti-Glomerular Basement Membrane Disease (therapy)
  • Arthritis, Rheumatoid (therapy)
  • Autoimmune Diseases (therapy)
  • Female
  • Humans
  • IgA Vasculitis (therapy)
  • Immune Complex Diseases (therapy)
  • Lupus Erythematosus, Systemic (therapy)
  • Male
  • Plasmapheresis
  • Vasculitis, Leukocytoclastic, Cutaneous (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: